Adial Pharmaceuticals ADIL
NASDAQ ADIL
$3.92 -0.30 (-7.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Gains from Investment Securities (2021 - 2023)

Updated

Analysis

Adial Pharmaceuticals (ADIL) Gains from Investment Securities (2021 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Adial Pharmaceuticals 18.37 Mn -25.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -195,574.00
Jun 30, 2023 15,690.00
Mar 31, 2023 -14,000.00
Dec 31, 2022 325,000.00
Sep 30, 2022 75,000.00
Jun 30, 2022 -24,000.00
Mar 31, 2022 146,000.00
Dec 31, 2021 54,014.00
Sep 30, 2021 -274,524.00
Jun 30, 2021 -67,478.00
Mar 31, 2021 6,275.00
API Access

Adial Pharmaceuticals Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ADIL&period=max&api_key=YOUR_API_KEY